Trend analysis of batch to batch consistency during quality assessment of biological medicinal products
Abstract
About the Author
D. S. DavydovRussian Federation
Head of the Laboratory of Bacteriophages and Normal Flora Preparations with the Collection of Microorganisms of the Testing Centre for Evaluation of Medicinal Immunobiological Products’ Quality. Candidate of Biological Sciences
References
1. Federal Law of April 12, 2010 ¹ 61-FZ «On Medicine Circulation» (in Russian).
2. Bases of state policy in the field of ensuring chemical and biological safety of the Russian Federation until 2025 and further prospect (approved by the President of the Russian Federation on November 1, 2013 ¹ Pr-2573) (in Russian).
3. Mironov AN, Supotnitskiy ÌV. Current state of immunobiological medicines expert evaluation in the Russian Federation. BIOpreparations. Prevention, Diagnosis, Treatment 2012; (1): 4–7 (in Russian).
4. ATC/DDD Index 2017. Available from: https://www.whocc.no/ atc_ddd_index.
5. Decree of the Government of the Russian Federation of December 1, 2009 ¹ 982«About the approval of the uniform list of production, the subject obligatory certification, and the uniform list of production which confirmation of compliance is carried out in the form of adoption of the declaration on compliance» (in Russian).
6. WHO harmonized National Regulatory Authority assessment tool (rev. 2014). World Health Organization, 2014. Available from: https://goo.gl/siLMTf.
7. ISO 28590:2017. Sampling procedures for inspection by attributes — Introduction to the ISO 2859 series of standards for sampling for inspection by attributes. Available from: https:// www.iso.org/standard/64622.html.
8. ISO 2859-1:1999. Sampling procedures for inspection by attributes — Part 1: Sampling schemes indexed by acceptance quality limit (AQL) for lot-by-lot inspection. Available from: https:// www.iso.org/standard/1141.html.
9. ISO 2859-2:1985. Sampling procedures for inspection by attributes — Part 2: Sampling plans indexed by limiting quality (LQ) for isolated lot inspection. Available from: https://www.iso.org/standard/7867.html.
10. ISO 2859-3:2005. Sampling procedures for inspection by attributes — Part 3: Skip-lot sampling procedures. Available from: https://www.iso.org/standard/34684.html.
11. ISO 2859-4:2002. Sampling procedures for inspection by attributes — Part 4: Procedures for assessment of declared quality levels. Available from: https://www.iso.org/standard/36164.html.
12. ISO 28591:2017. Sequential sampling plans for inspection by attributes. Available from: https://www.iso.org/ru/standard/64623.html.
13. Guidelines for Independent Lot Release of Vaccines by Regulatory Authorities. World Health Organization, 2010. Available from: https://goo.gl/XCTw1o.
14. ISO 7870-1:2014. Control charts — Part 1: General guidelines. Available from: https://www.iso.org/standard/62649.html.
15. Alekseeva IA, Chuprinina RP, Davydov DS. Assesment of consistency of technological process using control cards on the example of analysis of information on immunogenic activity of pertussis component of DTP vaccine. Zhurnal mikrobiologii, epidemiologii i immunobiologii 2009; (6) 70–5 (in Russian).
Review
For citations:
Davydov D.S. Trend analysis of batch to batch consistency during quality assessment of biological medicinal products. BIOpreparations. Prevention, Diagnosis, Treatment. 2017;17(4):230-232. (In Russ.)